CHOSA Oncology AB
Develops diagnostics and therapeutics for platinum-based chemotherapy.
CHOSA | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0007784319
- LEI:
- 5493002SFL9YXB0A0027
- Country:
- Sweden
- Address:
- C/O Medicon Village, C/O Medicon Village, Scheeletorget 1, 223 81 Lund
- Website:
- https://www.chosaoncology.com/
- Sector:
- Manufacturing
Description
CHOSA Oncology AB is a biotechnology company focused on advancing precision medicine for platinum-based chemotherapy. The company's strategy integrates diagnostics and therapeutics to personalize patient care. Its primary asset is Platin-DRP®, a patented diagnostic tool that analyzes a tumor's genetic profile to predict its response to cisplatin and carboplatin. This technology aims to improve survival rates and prevent the administration of ineffective, toxic treatments to non-responding patients. Complementing this is LiPlaCis®, a novel drug formulation that delivers cisplatin directly to tumors via a specialized liposome system, designed to enhance efficacy while minimizing side effects. The company's technologies are being validated in various cancers, including lung and breast cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CHOSA Oncology AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CHOSA Oncology AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CHOSA Oncology AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
